These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 18571091)

  • 1. Successful treatment of pseudophakic cystoid macular edema with intravitreal bevacizumab.
    Barone A; Prascina F; Russo V; Iaculli C; Primavera V; Querques G; Stella A; Delle Noci N
    J Cataract Refract Surg; 2008 Jul; 34(7):1210-2. PubMed ID: 18571091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of intravitreal bevacizumab in treating postoperative pseudophakic cystoid macular edema.
    Spitzer MS; Ziemssen F; Yoeruek E; Petermeier K; Aisenbrey S; Szurman P
    J Cataract Refract Surg; 2008 Jan; 34(1):70-5. PubMed ID: 18165084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term safety and efficacy of intravitreal bevacizumab for pseudophakic cystoid macular edema.
    Barone A; Russo V; Prascina F; Delle Noci N
    Retina; 2009 Jan; 29(1):33-7. PubMed ID: 18854783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal bevacizumab in postoperative pseudophakic cystoid macular edema: does it really work?
    Spitzer MS; Szurman P; Bartz-Schmidt KU
    J Cataract Refract Surg; 2008 Jun; 34(6):880; author reply 880-1. PubMed ID: 18498977
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravitreal bevacizumab for refractory pseudophakic cystoid macular edema: the Pan-American Collaborative Retina Study Group results.
    Arevalo JF; Maia M; Garcia-Amaris RA; Roca JA; Sanchez JG; Berrocal MH; Wu L;
    Ophthalmology; 2009 Aug; 116(8):1481-7, 1487.e1. PubMed ID: 19545901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary intravitreal bevacizumab for the management of pseudophakic cystoid macular edema: pilot study of the Pan-American Collaborative Retina Study Group.
    Arevalo JF; Garcia-Amaris RA; Roca JA; Sanchez JG; Wu L; Berrocal MH; Maia M;
    J Cataract Refract Surg; 2007 Dec; 33(12):2098-105. PubMed ID: 18053911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triamcinolone acetonide for refractory pseudophakic cystoid macular edema after intravitreal bevacizumab.
    Rodríguez-Blanco M; Marticorena J; Gómez-Ulla F
    Graefes Arch Clin Exp Ophthalmol; 2009 Mar; 247(3):427-8. PubMed ID: 18642017
    [No Abstract]   [Full Text] [Related]  

  • 8. Intravitreal bevacizumab (Avastin) for refractory pseudophakic cystoid macular edema.
    Mason JO; Albert MA; Vail R
    Retina; 2006 Mar; 26(3):356-7. PubMed ID: 16508440
    [No Abstract]   [Full Text] [Related]  

  • 9. Analysis of the effect of intravitreal bevacizumab injection on diabetic macular edema after cataract surgery.
    Takamura Y; Kubo E; Akagi Y
    Ophthalmology; 2009 Jun; 116(6):1151-7. PubMed ID: 19376589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal bevacizumab (Avastin) for the treatment of cystoid macular edema in Behçet disease.
    Mirshahi A; Namavari A; Djalilian A; Moharamzad Y; Chams H
    Ocul Immunol Inflamm; 2009; 17(1):59-64. PubMed ID: 19294576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phacoemulsification with intravitreal bevacizumab injection in diabetic patients with macular edema and cataract.
    Akinci A; Batman C; Ozkilic E; Altinsoy A
    Retina; 2009; 29(10):1432-5. PubMed ID: 19898181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OCT and cataract.
    Falavarjani KG; Modarres M; Nikeghbali A
    Ophthalmology; 2010 Apr; 117(4):849; author reply 849-50. PubMed ID: 20346827
    [No Abstract]   [Full Text] [Related]  

  • 13. Intraocular triamcinolone acetonide for pseudophakic cystoid macular edema: optical coherence tomography and multifocal electroretinography study.
    Koutsandrea C; Moschos MM; Brouzas D; Loukianou E; Apostolopoulos M; Moschos M
    Retina; 2007 Feb; 27(2):159-64. PubMed ID: 17290196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.
    Haritoglou C; Kook D; Neubauer A; Wolf A; Priglinger S; Strauss R; Gandorfer A; Ulbig M; Kampik A
    Retina; 2006; 26(9):999-1005. PubMed ID: 17151486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal bevacizumab for treatment of uveitic macular edema.
    Cordero Coma M; Sobrin L; Onal S; Christen W; Foster CS
    Ophthalmology; 2007 Aug; 114(8):1574-1579.e1. PubMed ID: 17363060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bevacizumab and macular edema.
    Kumar A
    Ophthalmology; 2008 Mar; 115(3):585. PubMed ID: 18319106
    [No Abstract]   [Full Text] [Related]  

  • 17. Intravitreal injection of bevacizumab for cystoid macular edema in retinitis pigmentosa.
    Melo GB; Farah ME; Aggio FB
    Acta Ophthalmol Scand; 2007 Jun; 85(4):461-3. PubMed ID: 17313405
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.
    Kook D; Wolf A; Kreutzer T; Neubauer A; Strauss R; Ulbig M; Kampik A; Haritoglou C
    Retina; 2008 Oct; 28(8):1053-60. PubMed ID: 18779710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinal sensitivity after intravitreal injection of bevacizumab for the treatment of macular edema secondary to retinal vein occlusion.
    Yamaike N; Tsujikawa A; Sakamoto A; Ota M; Kotera Y; Miyamoto K; Kita M; Yoshimura N
    Retina; 2009 Jun; 29(6):757-67. PubMed ID: 19289982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal bevacizumab treatment of macular edema due to optic disc vasculitis.
    Erdurman FC; Durukan AH; Mumcuoğlu T; Hürmeriç V
    Ocul Immunol Inflamm; 2009; 17(1):56-8. PubMed ID: 19294575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.